Clinical Trials Browser

Small Cell Lung Carcinoma

Extensive Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

Non-Squamous Non-Small Cell Lung Cancer

SCLC,Extensive Stage

Lung Neoplasms

EGFR Positive Non-small Cell Lung Cancer

Untreated Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms, Postoperative Complications

Lung Neoplasms

Lung Neoplasms, Colorectal Neoplasms

Lung Neoplasms

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Small Cell Lung Carcinoma

Non-small Cell Lung Cancer Confirmed by Histopathology or Cytology

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

EGFR Positive Non-small Cell Lung Cancer

Small Cell Lung Cancer Recurrent

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Advanced Non-small-cell Lung Cancer

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

Lung Neoplasms, Smoking

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Small Cell Lung Carcinoma

Advanced NSCLC With EGFR Mutation

Adenocarcinoma of Lung

Small Cell Lung Carcinoma

Non-squamous Cell Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Locally Advanced Non Small Cell Lung Cancer

Small Cell Lung Cancer Extensive Stage

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Non-squamous Non-small Cell Lung Cancer

Lung Neoplasms

Adenocarcinoma of Lung

Lung Neoplasms

Adenocarcinoma of Lung

Clinical Trials

First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy

A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure

SCLC

Novel Light Delivery Method for Performing Transbronchial Photodynamic Therapy for Peripheral Lung Cancer

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer

Brigatinib in ALK-positive NSCLC Identified Via Blood-based Assays

The Effect of Nutritional Risk Parameters on Postoperative Pulmonary Complications in Geriatric Thoracic Surgery Cases

qUEST

EMBRaCE-GM

Cost-effectiveness Evaluation of Robotic Surgery in the Removal of Lung Lesions in the ATS of Milan

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma

Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer

Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer

NSCLC

the Efficacy and Safety of Dalpiciclib Combined With Third-generation EGFR-TKI in Patients With EGFR Mutation and Meningial Metastasis in Non-small Cell Lung Cancer Progressing Through Third-generation TKI and Platinum-containing Two-drug Chemotherapy

Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer

Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations

AvaTa

Atezolizumab

Study of Lorlatinib in ROS1 Rearranged NSCLC

Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10%

Utidelone in Third-line and Above Treatment of Small Cell Lung Cancer

An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLC

Tislelizumab as Cross-line Treatment for Advanced NSCLC

CAMERA

SPORT

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

ITLUCAS

Novel Light Delivery Methods for Lung Cancer Photodynamic Therapy - A Pilot Study

Toripalimab as Maintenance Therapy in Patients With Driver-gene Negative Advanced NSCLC After First-line Chemotherapy

MWA in NSCLC

Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer

S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLC

Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation

Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer

Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC

Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC

Study of CT and MR in the Lung Cancer

Sleep Apnea and Lung Cancer

Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer

SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer

PIN

Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel

Microwave Ablation in Ground Glass Nodules

Geber

K-LUCAS

Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma